Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
Tibet Rhodiola Pharmaceutical Holding Co
Cash from Operating Activities
Tibet Rhodiola Pharmaceutical Holding Co
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
|
Cash from Operating Activities
¥1.1B
|
CAGR 3-Years
35%
|
CAGR 5-Years
30%
|
CAGR 10-Years
14%
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Cash from Operating Activities
¥11.9B
|
CAGR 3-Years
38%
|
CAGR 5-Years
33%
|
CAGR 10-Years
11%
|
|
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Cash from Operating Activities
¥5.2B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
11%
|
CAGR 10-Years
18%
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Cash from Operating Activities
¥6.3B
|
CAGR 3-Years
15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Cash from Operating Activities
¥2.7B
|
CAGR 3-Years
28%
|
CAGR 5-Years
23%
|
CAGR 10-Years
31%
|
Huadong Medicine Co Ltd
SZSE:000963
|
Cash from Operating Activities
¥3.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
See Also
What is Tibet Rhodiola Pharmaceutical Holding Co's Cash from Operating Activities?
Cash from Operating Activities
1.1B
CNY
Based on the financial report for Dec 31, 2023, Tibet Rhodiola Pharmaceutical Holding Co's Cash from Operating Activities amounts to 1.1B CNY.
What is Tibet Rhodiola Pharmaceutical Holding Co's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
14%
Over the last year, the Cash from Operating Activities growth was 27%. The average annual Cash from Operating Activities growth rates for Tibet Rhodiola Pharmaceutical Holding Co have been 35% over the past three years , 30% over the past five years , and 14% over the past ten years .